32O First-in-human (FIH) study of SCC244, a novel potent and highly selective c- MET inhibitor, in patients (pts) with advanced non-small cell lung cancer (NSCLC)
Titel:
32O First-in-human (FIH) study of SCC244, a novel potent and highly selective c- MET inhibitor, in patients (pts) with advanced non-small cell lung cancer (NSCLC)
Auteur:
Chen, H-J. Yang, J-J. Zhou, J-Y. Zhao, J. Sun, Y-P. Wen, Q. Zhou, Q. Zhang, Z. Tu, H-Y. Zhou, J-Y. Zhang, P. Chen, X. Chen, H-X. Dang, Q. Sun, M-H. Li, Y. Wu, Y-L.